PKU: Niet altijd 'PKU'

E. A. Croonen; A. I. Jonckheere; E. Morava

doi:10.1007/BF03555598

PKU: Niet altijd 'PKU'

Translated title of the contribution: Phenylketonuria (PKU): Not always 'PKU'

E. A. Croonen, A. I. Jonckheere, E. Morava

Medical Genetics

Research output: Contribution to journal › Article › peer-review

Abstract

Neonatal screening aims to detect serious but treatable diseases in neonates. A positive screening for phenylketonuria (PKU) does not necessarily mean hyperphenylalaninemia as a consequence of classic PKU. We report on a female patient diagnosed with dihydropteridin reductase (DHPR) deficiency through neonatal screening. This is a rare inborn error of the biopterin metabolism, characterized by a more severe neurological involvement compared to classic PKU. A diagnostic oral tetrahydrobiopterin (BH4) loading test was performed in our patient followed by detailed metabolic investigations of the pterin metabolism to confirm the correct diagnosis of DHPR deficiency. Despite adequate treatment by suppletion of BH4, folinic acid, L-dopa/carbidopa (Sinemet®) and L-5-hydroxytryptophan (Oxitriptan®) the patient deceased suddenly at the age of 10 months.

Translated title of the contribution	Phenylketonuria (PKU): Not always 'PKU'
Original language	Dutch
Pages (from-to)	183-186
Number of pages	4
Journal	Tijdschrift voor Kindergeneeskunde
Volume	78
Issue number	5
DOIs	https://doi.org/10.1007/BF03555598
State	Published - Oct 2010

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1007/BF03555598

Cite this

@article{82f34457e0034a5e8e3f86b7bd2108a6,

title = "PKU: Niet altijd 'PKU'",

abstract = "Neonatal screening aims to detect serious but treatable diseases in neonates. A positive screening for phenylketonuria (PKU) does not necessarily mean hyperphenylalaninemia as a consequence of classic PKU. We report on a female patient diagnosed with dihydropteridin reductase (DHPR) deficiency through neonatal screening. This is a rare inborn error of the biopterin metabolism, characterized by a more severe neurological involvement compared to classic PKU. A diagnostic oral tetrahydrobiopterin (BH4) loading test was performed in our patient followed by detailed metabolic investigations of the pterin metabolism to confirm the correct diagnosis of DHPR deficiency. Despite adequate treatment by suppletion of BH4, folinic acid, L-dopa/carbidopa (Sinemet{\textregistered}) and L-5-hydroxytryptophan (Oxitriptan{\textregistered}) the patient deceased suddenly at the age of 10 months.",

author = "Croonen, {E. A.} and Jonckheere, {A. I.} and E. Morava",

year = "2010",

month = oct,

doi = "10.1007/BF03555598",

language = "Dutch",

volume = "78",

pages = "183--186",

journal = "Tijdschrift voor Kindergeneeskunde",

issn = "0376-7442",

publisher = "Bohn Stafleu van Loghum",

number = "5",

}

TY - JOUR

T1 - PKU

T2 - Niet altijd 'PKU'

AU - Croonen, E. A.

AU - Jonckheere, A. I.

AU - Morava, E.

PY - 2010/10

Y1 - 2010/10

N2 - Neonatal screening aims to detect serious but treatable diseases in neonates. A positive screening for phenylketonuria (PKU) does not necessarily mean hyperphenylalaninemia as a consequence of classic PKU. We report on a female patient diagnosed with dihydropteridin reductase (DHPR) deficiency through neonatal screening. This is a rare inborn error of the biopterin metabolism, characterized by a more severe neurological involvement compared to classic PKU. A diagnostic oral tetrahydrobiopterin (BH4) loading test was performed in our patient followed by detailed metabolic investigations of the pterin metabolism to confirm the correct diagnosis of DHPR deficiency. Despite adequate treatment by suppletion of BH4, folinic acid, L-dopa/carbidopa (Sinemet®) and L-5-hydroxytryptophan (Oxitriptan®) the patient deceased suddenly at the age of 10 months.

AB - Neonatal screening aims to detect serious but treatable diseases in neonates. A positive screening for phenylketonuria (PKU) does not necessarily mean hyperphenylalaninemia as a consequence of classic PKU. We report on a female patient diagnosed with dihydropteridin reductase (DHPR) deficiency through neonatal screening. This is a rare inborn error of the biopterin metabolism, characterized by a more severe neurological involvement compared to classic PKU. A diagnostic oral tetrahydrobiopterin (BH4) loading test was performed in our patient followed by detailed metabolic investigations of the pterin metabolism to confirm the correct diagnosis of DHPR deficiency. Despite adequate treatment by suppletion of BH4, folinic acid, L-dopa/carbidopa (Sinemet®) and L-5-hydroxytryptophan (Oxitriptan®) the patient deceased suddenly at the age of 10 months.

UR - http://www.scopus.com/inward/record.url?scp=81755181458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81755181458&partnerID=8YFLogxK

U2 - 10.1007/BF03555598

DO - 10.1007/BF03555598

M3 - Article

AN - SCOPUS:81755181458

SN - 0376-7442

VL - 78

SP - 183

EP - 186

JO - Tijdschrift voor Kindergeneeskunde

JF - Tijdschrift voor Kindergeneeskunde

IS - 5

ER -

PKU: Niet altijd 'PKU'

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this